Fiber choledochoscope in treatment of patients with biliary cast syndrome after liver transplantation
10.3877/cma.j.issn.2095-3232.2018.03.009
- VernacularTitle:纤维胆道镜治疗肝移植术后胆道铸型综合征
- Author:
Jing YANG
1
;
Tao LIU
;
Lin SUN
;
Guangxiang JIA
;
Yunjin ZANG
;
Xiao HU
Author Information
1. 266003,青岛大学附属医院肝胆外科
- Keywords:
Liver transplantation;
Biliary cast syndrome;
Choledochoscope
- From:
Chinese Journal of Hepatic Surgery（Electronic Edition）
2018;7(3):202-205
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the safety and efficacy of fiber choledochoscope in the treatment of patients with biliary cast syndrome (BCS) after liver transplantation (LT).Methods Clinical data of 10 patients with BCS after LT treated with fiber choledochoscope in the Affiliated Hospital of Qingdao University between March 2014 and June 2016 were analyzed retrospectively. There were 8 males and 2 females, aged 46-66 years old and the median age was 50 years old. The primary diseases of the patients were primary liver cancer (n=6), biliary cirrhosis (n=1), hepatic cirrhosis after hepatitis B (n=2), and hepatic cirrhosis after hepatitis C (n=1). The informed consents of all patients were obtained and the local ethical committee approval was received. For patients with BCS in the early stage after LT, T tube was replaced. For patients in late stage after LT, T tube fistula dilatation was performed, then biliary cast (BC) was removed and the supporting drainage tube was placed.Results 2 cases received T tube replacement when in early stage after LT, 8 received T tube fistula dilatation when in late stage after LT. All 10 cases had BC removed successfully with fiber choledochoscope. Liver function of 8 cases returned to normal after surgery, and the biliary drainage tube was removed. 2 cases had BC again and recurrent biliary infection, and then received PTCD drainage. Conclusion Fiber choledochoscope is safe, effective and feasible for the treatment of BCS after LT.
